Literature DB >> 26740107

Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.

Tâm D Quách1, Nely Rodríguez-Zhurbenko2, Thomas J Hopkins1, Xiaoti Guo1, Ana María Hernández2, Wentian Li3, Thomas L Rothstein4.   

Abstract

Human Ab-secreting cell (ASC) populations in circulation are not well studied. In addition to B-1 (CD20(+)CD27(+)CD38(lo/int)CD43(+)) cell and conventional plasmablast (PB) (CD20-CD27(hi)CD38(hi)) cell populations, in this study, we identified a novel B cell population termed 20(+)38(hi) B cells (CD20(+)CD27(hi)CD38(hi)) that spontaneously secretes Ab. At steady-state, 20(+)38(hi) B cells are distinct from PBs on the basis of CD20 expression, amount of Ab production, frequency of mutation, and diversity of BCR repertoire. However, cytokine treatment of 20(+)38(hi) B cells induces loss of CD20 and acquisition of CD138, suggesting that 20(+)38(hi) B cells are precursors to PBs or pre-PBs. We then evaluated similarities and differences among CD20(+)CD27(+)CD38(lo/int)CD43(+) B-1 cells, CD20(+)CD27(hi)CD38(hi) 20(+)38(hi) B cells, CD20(-)CD27(hi)CD38(hi) PBs, and CD20(+)CD27(+)CD38(lo/int)CD43(-) memory B cells. We found that B-1 cells differ from 20(+)38(hi) B cells and PBs in a number of ways, including Ag expression, morphological appearance, transcriptional profiling, Ab skewing, Ab repertoire, and secretory response to stimulation. In terms of gene expression, B-1 cells align more closely with memory B cells than with 20(+)38(hi) B cells or PBs, but differ in that memory B cells do not express Ab secretion-related genes. We found that B-1 cell Abs use Vh4-34, which is often associated with autoreactivity, 3- to 6-fold more often than other B cell populations. Along with selective production of IgM anti-phosphoryl choline, these data suggest that human B-1 cells might be preferentially selected for autoreactivity/natural specificity. In summary, our results indicate that human healthy adult peripheral blood at steady-state consists of three distinct ASC populations.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26740107      PMCID: PMC5351554          DOI: 10.4049/jimmunol.1501843

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

1.  Regulation of B-1 cell activation and its autoantibody production by Lyn kinase-regulated signallings.

Authors:  H Ochi; H Takeshita; T Suda; S Nisitani; T Honjo; T Watanabe
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

Authors:  H Masmoudi; T Mota-Santos; F Huetz; A Coutinho; P A Cazenave
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

3.  Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults.

Authors:  F Eun-Hyung Lee; Ann R Falsey; Jessica L Halliley; Iñaki Sanz; Edward E Walsh
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

4.  B1 and B2 cells differ in their potential to switch immunoglobulin isotype.

Authors:  D M Tarlinton; M McLean; G J Nossal
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

5.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

6.  Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow.

Authors:  Julia I Ellyard; Danielle T Avery; Tri Giang Phan; Nathan J Hare; Philip D Hodgkin; Stuart G Tangye
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

7.  Immune-cell lineage commitment: translation from mice to humans.

Authors:  Kimberly J Payne; Gay M Crooks
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

8.  A human equivalent of mouse B-1 cells?

Authors:  Marc Descatoire; Jean-Claude Weill; Claude-Agnès Reynaud; Sandra Weller
Journal:  J Exp Med       Date:  2011-12-19       Impact factor: 14.307

9.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

10.  Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline.

Authors:  T J Mercolino; A L Locke; A Afshari; D Sasser; W W Travis; L W Arnold; G Haughton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  48 in total

1.  Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.

Authors:  Mariana Silva; Ronald Kam Fai Fung; Conor Brian Donnelly; Paula Alexandra Videira; Robert Sackstein
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

2.  B cell homeostasis is maintained during long-duration spaceflight.

Authors:  Guillaume Spielmann; Nadia Agha; Hawley Kunz; Richard J Simpson; Brian Crucian; Satish Mehta; Mitzi Laughlin; John Campbell
Journal:  J Appl Physiol (1985)       Date:  2018-11-29

Review 3.  Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.

Authors:  Grayson Beecher; Brendan Nicholas Putko; Amanda Nicole Wagner; Zaeem Azfer Siddiqi
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

Review 4.  B cells in the pathophysiology of myasthenia gravis.

Authors:  John S Yi; Jeffrey T Guptill; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

5.  2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.

Authors:  Aditi Upadhye; Jeffrey M Sturek; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 8.311

6.  Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis.

Authors:  Panos Stathopoulos; Aditya Kumar; Richard J Nowak; Kevin C O'Connor
Journal:  JCI Insight       Date:  2017-09-07

Review 7.  Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Authors:  Mohan S Maddur; Sébastien Lacroix-Desmazes; Jordan D Dimitrov; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

8.  Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.

Authors:  Tâm D Quách; Thomas J Hopkins; Nichol E Holodick; Raja Vuyyuru; Tim Manser; Ruthee-Lu Bayer; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

9.  Immunological Responses to the Relapsing Fever Spirochete Borrelia turicatae in Infected Rhesus Macaques: Implications for Pathogenesis and Diagnosis.

Authors:  Monica E Embers; Aparna Krishnavajhala; Brittany A Armstrong; Michael W Curtis; Bapi Pahar; Hannah K Wilder; Michael S Allen; Paul A Beare; Nicole R Hasenkampf; Job E Lopez
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

10.  Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.

Authors:  Aditi Upadhye; Prasad Srikakulapu; Ayelet Gonen; Sabrina Hendrikx; Heather M Perry; Anh Nguyen; Chantel McSkimming; Melissa A Marshall; James C Garmey; Angela M Taylor; Timothy P Bender; Sotirios Tsimikas; Nichol E Holodick; Thomas L Rothstein; Joseph L Witztum; Coleen A McNamara
Journal:  Circ Res       Date:  2019-09-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.